Taxespira (previously Docetaxel Hospira UK Limited ) European Union - English - EMA (European Medicines Agency)

taxespira (previously docetaxel hospira uk limited )

hospira uk limited - docetaxel trihydrate - stomach neoplasms; prostatic neoplasms; breast neoplasms; head and neck neoplasms; carcinoma, non-small-cell lung - antineoplastic agents - breast cancertaxespira in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with:operable node-positive breast cancer;operable node-negative breast cancer.for patients with operable node-negative breast cancer, adjuvant treatment should be restricted to patients eligible to receive chemotherapy according to internationally established criteria for primary therapy of early breast cancer.taxespira in combination with doxorubicin is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have not previously received cytotoxic therapy for this condition.taxespira monotherapy is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic therapy. previous chemotherapy should have included an anthracycline or an alkylating agent.taxespira combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumours over express her2 and who previously have not received chemotherapy for metastatic disease.taxespira in combination with capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic chemotherapy. previous therapy should have included an anthracycline.non-small cell lung cancer taxespira indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of prior chemotherapy.taxespira in combination with cisplatin is indicated for the treatment of patients with unresectable, locally advanced or metastatic non-small cell lung cancer, in patients who have not previously received chemotherapy for this condition.prostate cancer taxespira in combination with prednisone or prednisolone is indicated for the treatment of patients with hormone refractory metastatic prostate cancer.gastric adenocarcinoma taxespira in combination with cisplatin and 5-fluorouracil is indicated for the treatment of patients with metastatic gastric adenocarcinoma, including adenocarcinoma of the gastroesophageal junction, who have not received prior chemotherapy for metastatic disease.head and neck cancer taxespira in combination with cisplatin and 5-fluorouracil is indicated for the induction treatment of patients with locally advanced squamous cell carcinoma of the head and neck.

None 100mg/ mL (1g/10mL) Solution for Injection (IM/IV/IA) Philippines - English - FDA (Food And Drug Administration)

none 100mg/ ml (1g/10ml) solution for injection (im/iv/ia)

hospira philippines, inc.; distributor: hospira philippines, inc. - methotrexate - solution for injection (im/iv/ia) - 100mg/ ml (1g/10ml)

None 4g/ 500mg Lyophilized Powder for IV Injection Philippines - English - FDA (Food And Drug Administration)

none 4g/ 500mg lyophilized powder for iv injection

hospira philippines inc; distributor: hospira philippines inc - piperacillin (as sodium) , tazobactam (as sodium) - lyophilized powder for iv injection - 4g/ 500mg

None 25mg/ mL (500mg/20mL) Solution for Injection (IM/IV/IA) Philippines - English - FDA (Food And Drug Administration)

none 25mg/ ml (500mg/20ml) solution for injection (im/iv/ia)

hospira philippines, inc.; distributor: hospira philippines, inc. - methotrexate - solution for injection (im/iv/ia) - 25mg/ ml (500mg/20ml)

None 10mg/ mL (50mg/5mL) Concentrate for Solution for Injection (IV) Philippines - English - FDA (Food And Drug Administration)

none 10mg/ ml (50mg/5ml) concentrate for solution for injection (iv)

hospira philippines, inc.; distributor: hospira philippines, inc. - vinorelbine (as tartrate) - concentrate for solution for injection (iv) - 10mg/ ml (50mg/5ml)

Cefoxitin (As Sodium) 1g Powder for Injection Philippines - English - FDA (Food And Drug Administration)

cefoxitin (as sodium) 1g powder for injection

hospira philippines, inc. - cefoxitin (as sodium) - powder for injection - 1g

Luminal 130mg / mL Solution for Injection Philippines - English - FDA (Food And Drug Administration)

luminal 130mg / ml solution for injection

hospira philippines, inc. - phenobarbital sodium - solution for injection - 130mg / ml

None 10mg/ mL Solution for Intravenous Infusion Philippines - English - FDA (Food And Drug Administration)

none 10mg/ ml solution for intravenous infusion

hospira philippines inc; distributor: globo asiatico enterprises, inc. - carboplatin - solution for intravenous infusion - 10mg/ ml

None 4mg/ 5mL Concentrate Solution for Infusion (IV) Philippines - English - FDA (Food And Drug Administration)

none 4mg/ 5ml concentrate solution for infusion (iv)

hospira philippines, inc. - zoledronic acid - concentrate solution for infusion (iv) - 4mg/ 5ml